#2505888
Feistí solaschomharthaíochta (LSD)
Light signalling devices (LSD)
Filter results
Collections
12 results in 3 documents
#2720218
Iarscríbhinn IX maidir le vacsaíniú in aghaidh ionfhabhtú le galar an chraicinn chnapánaigh (LSD).
Annex IX on vaccination against infection with lumpy skin disease virus (LSD).
#2720450
Ionfhabhtú le galar an chraicinn chnapánaigh (LSD)
Infection with lumpy skin disease virus (LSD)
#1825529
Togra le haghaidh Fhorlíonadh 2 a ghabhann leis an tsraith bhunaidh de Rialachán Uimh. 148 de chuid NA maidir le feistí solaschomharthaíochta (LSD)
Proposal for Supplement 2 to the original series of UN Regulation No 148 on Light-Signalling Devices (LSD)
#2720451
COINNÍOLLACHA SONRACHA MAIDIR LE CUR CHUN FEIDHME VACSAÍNITHE PRÓIFIOLACSAIGH ÉIGEANDÁLA CHUN LSD A CHOSC AGUS A RIALÚ
SPECIFIC CONDITIONS FOR THE IMPLEMENTATION OF EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD
#2720453
Crios vacsaínithe I: crios vacsaínithe ina gcuirtear vacsaíniú próifiolacsach éigeandála chun feidhme i limistéir nach bhfuil LSD deimhnithe iontu;
Vaccination zone I: vaccination zone where emergency protective vaccination is implemented in areas where LSD has not been confirmed;
#2720454
Crios vacsaínithe II: crios vacsaínithe ina gcuirtear vacsaíniú próifiolacsach éigeandála chun feidhme i limistéir a bhfuil ráigeanna LSD deimhnithe iontu.
Vaccination zone II: vaccination zone where emergency protective vaccination is implemented in areas where outbreaks of LSD have been confirmed.
#2720460
COINNÍOLLACHA SONRACHA MAIDIR LE FAIREACHAS TREISITHE CLINICIÚIL AGUS SAOTHARLAINNE ATÁ LE CUR CHUN FEIDHME SNA CRIOSANNA VACSAÍNITHE AGUS PEIREA-VACSAÍNITHE LE LINN VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN LSD A CHOSC AGUS A RIALÚ
SPECIFIC CONDITIONS FOR THE REINFORCED CLINICAL AND LABORATORY SURVEILLANCE TO BE IMPLEMENTED IN THE VACCINATION AND PERI-VACCINATION ZONES DURING EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD
#2720535
8 mí tar éisan vacsaínithe deiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe I), tréimhse ar lena linn nár léiríodh le faireachas cliniciúil agus saotharlainne aon tarlú de LSD
8 months after the last vaccination if emergency protective vaccination has been used (in vaccination zone I), and during which period clinical and laboratory surveillance has demonstrated no occurrence of LSD
#2720507
cuireadh na hainmhithe bronntacha faoi réir tástála um imoibriú slabhrúil polaiméaráise (PCR) chun LSD a bhrath, a raibh torthaí diúltach uirthi, a rinneadh ar shamplaí fola a bailíodh ag tús bhailiú an tseamhain agus gach 14 lá ar a laghad ina dhiaidh sin le linn thréimhse bailithe an tseamhain nó ar an lá bailithe maidir le suthanna agus úicítí;
the donor animals were subjected, with negative results, to a polymerase chain reaction (PCR) test to detect LSD conducted on blood samples collected at the commencement of collection of the semen and at least every 14 days thereafter during the semen collection period or on the day of collection for embryos and oocytes;
#2720531
14 mhí tar éis mharú seamlais nó mharú an cháis dheireanaigh, nó tar éis anvacsaínithe deiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe II), cibé acu is déanaí a tharla, tréimhse ar lena linn nár léiríodh le faireachas cliniciúil agus saotharlainne aon tarlú de LSD
14 months after the slaughter or killing of the last case, or after the last vaccination if emergency protective vaccination has been used (in vaccination zone II), whichever occurred last, and during which period clinical and laboratory surveillance has demonstrated no occurrence of LSD
#2720533
26 mhí tar éis marú seamlais nó marú an cháis dheireanaigh, nó tar éis anvacsaínithedeiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe II), cibé acu is déanaí a tharla, tréimhse ar lena linn nár léiríodh le faireachas cliniciúil amháin aon tarlú de LSD
26 months after the slaughter or killing of the last case, or after the last vaccination if emergency protective vaccination has been used (in vaccination zone II), whichever occurred last, and during which period clinical surveillance alone has demonstrated no occurrence of LSD